{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:45:46Z","timestamp":1763747146653,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.3816\/clml.2011.n.042","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T15:21:35Z","timestamp":1352820095000},"page":"176-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Heterogeneity of Histological Transformation Events in Waldenstr\u00f6m's Macroglobulinemia (WM) and Related Disorders"],"prefix":"10.3816","volume":"11","author":[{"given":"R G","family":"Owen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A G","family":"Bynoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"de Tute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A C","family":"Rawstron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLML.2011.n.042_bib1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.1993.11.8.1553","article-title":"Prognostic factors in Waldenstrom's macroglobulinemia: a report of 167 cases","volume":"11","author":"Facon","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.042_bib2","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.1998.16.6.2060","article-title":"Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: a report of 71 cases. Groupe Cooperatif Macroglobulinemie","volume":"16","author":"Leblond","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.042_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","article-title":"Waldenstrom's macroglobulinaemia: presenting features and outcome in a series with 217 cases","volume":"115","author":"Garcia-Sanz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLML.2011.n.042_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1309\/4LCN-JMPG-5U71-UWQB","article-title":"Waldenstrom macroglobulinemia: Development of diagnostic criteria and identification of prognostic factors","volume":"116","author":"Owen","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLML.2011.n.042_bib5","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood.V98.9.2640","article-title":"Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease","volume":"98","author":"Leblond","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.042_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/R01VXG46MFCDVNHL","article-title":"Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases","volume":"120","author":"Lin","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLML.2011.n.042_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.leu.2403885","article-title":"Fludarabine plus cyclophosphamide in Waldenstrom's macroglobulinemia: results in 49 patients","volume":"19","author":"Tamburini","year":"2005","journal-title":"Leukemia"},{"key":"10.3816\/CLML.2011.n.042_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.20773","article-title":"Richter syndrome: biology, incidence, and therapeutic strategies","volume":"103","author":"Tsimberidou","year":"2005","journal-title":"Cancer"},{"key":"10.3816\/CLML.2011.n.042_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.leukres.2004.09.008","article-title":"Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis","author":"Thornton","year":"2005","journal-title":"Leuk Res"},{"key":"10.3816\/CLML.2011.n.042_bib10","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.042_bib11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cncr.22121","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: the MD Anderson Cancer Center experience","volume":"107","author":"Tsimberidou","year":"2006","journal-title":"Cancer"},{"key":"10.3816\/CLML.2011.n.042_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1200\/JCO.2007.15.1530","article-title":"Increased incidence of transformation and myelodysplasia\/acute leukemia in patients with Waldenstr\u00f6m macroglobulinemia treated with nucleoside analogs","volume":"27","author":"Leleu","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.042_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3816\/CLM.2009.n.018","article-title":"Balancing risk versus benefit in the treatment of Waldenstrom's macroglobulinemia patients with nucleoside analogue-based therapy","volume":"9","author":"Leleu","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLML.2011.n.042_bib14","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1080\/10428190802123481","article-title":"Development of EBV-associated diffuse large B-cell lymphoma in Waldenstrom macroglobulinemia and mantle cell lymphoma","volume":"49","author":"Varghese","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLML.2011.n.042_bib15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLML.2011.n.042_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer \u2013 A study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLML.2011.n.042_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLML.2011.n.042_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12253-009-9233-2","article-title":"Pheno- and genotypic features of Epstein-Barr virus associated B-cell lymphoproliferations in peripheral T-cell lymphomas","volume":"16","author":"Smuk","year":"2010","journal-title":"Pathol Oncol Res"},{"key":"10.3816\/CLML.2011.n.042_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.2007.06969.x","article-title":"IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)","volume":"140","author":"Feyler","year":"2008","journal-title":"Br J Haematol"},{"key":"10.3816\/CLML.2011.n.042_bib20","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2007.15.9475","article-title":"Phenotypic evolution of Waldenstrom's macroglobulinemia to extramedullary plasmacytoma","volume":"26","author":"Bashir","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.042_bib21","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood-2003-01-0045","article-title":"Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone","volume":"102","author":"Sanchez","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.042_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.LAB.0000050762.61660.27","article-title":"Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders","volume":"83","author":"Kremer","year":"2003","journal-title":"Lab Invest"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501170163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501170163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:23:22Z","timestamp":1761870202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226501170163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S215226501170163X"],"URL":"https:\/\/doi.org\/10.3816\/clml.2011.n.042","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity of Histological Transformation Events in Waldenstr\u00f6m's Macroglobulinemia (WM) and Related Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLML.2011.n.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}